kinds of diseases and symptoms

The largest blog for reading the latest medical research on all disease, the prevention and its treatment . Pulled from variety of sources

Monday, August 1, 2016

Home / Disease / GlaxoSmithKline and Google’s life science wing form new bioelectronic medicine company : techcrunch

GlaxoSmithKline and Google’s life science wing form new bioelectronic medicine company : techcrunch

Author: in : label :




according to techcrunch

GlaxoSmithKline and Google's life science wing form new bioelectronic medicine company

GlaxoSmithKline and Google's life science wing form new bioelectronic medicine company
GlaxoSmithKline and Google's life science wing form new bioelectronic medicine company
A fortnight after offering news that it will be using Apple's ReasearchKit to conduct arthritis research, drug giant GlaxoSmithKline has announced that it will be teaming with Verily, the Alphabet-owned LLC formerly known as Google Life Sciences, to create Galvani Bioelectronics.The jointly owned venture (55-percent GSK, 45-percent Verily) will work to explore bioelectronic medicine, a field that utilizes tiny implanted devices to alter nerve impulses with electrical signals.The space is believed to have potential to impact such conditions as arthritis, diabetes and asthma.Initial work by the fledgling company will focus on disorders like type 2 diabetes.






in the same way theverge

GlaxoSmithKline and Google team up to create new bioelectronics health company

GlaxoSmithKline and Google team up to create new bioelectronics health company
GlaxoSmithKline and Google team up to create new bioelectronics health company
British pharmaceutical giant GlaxoSmithKline and Google's parent company Alphabet have announced they're creating a new company to develop bioelectronic medicines.The joint venture will be named Galvani Bioelectronics and will be headquartered in the UK, with 55 percent of equity interest owned by GSK and 45 percent owned by Alphabet's Verily Life Sciences division (formerly known as Google Life Sciences).Galvani will initially be funded with £540 million over the next seven years ($712 million), and plans to have treatments ready for regulatory approval by 2023.bioelectronics uses electrical pulses to stimulate parts of the bodyBioelectronics is a relatively new branch of health care, which as the name suggests, focuses on bringing together electronics and biological research.The term can cover a number of different therapies, but GSK plans to concentrate on creating electrical implants that can be used to treat diseases.


let alone thestreet

GlaxoSmithKline (GSK) Chairman Slaoui to CNBC: Bioelectronics a 'Whole new Industry'

GlaxoSmithKline (GSK) Chairman Slaoui to CNBC: Bioelectronics a 'Whole new Industry'
GlaxoSmithKline (GSK) Chairman Slaoui to CNBC: Bioelectronics a 'Whole new Industry'
Kanye Tweets Apple (AAPL) Should Buy Tidal, Columnists React on CNBCCould a Spin-off of its Hepatitis C Division be in Gilead's Future?These 5 Stocks Are Set to Soar on Bullish Earnings4 Big-Volume Stocks to Add to Your Buy List -- Plus 3 to AvoidForget About Ford's Weak Earnings Report -- Now Is the Time to Buy This StockStocks Fluctuate as Biotech Gains, Energy DropsHere Is Why Chipotle's Burger Idea Could Give Investors HeartburnExxon (XOM) Stock Lower, Price Target Cut at Barclays3 Highest-Yielding Dividend Aristocrat Stocks Provide Income and Safety35 Best Flexible Part-Time JobsWhy Keryx Biopharmaceuticals (KERX) Stock Is Plummeting TodayWarren Buffett's Top 10 Dividend-Paying Stocks for 2016Tesla Motors' (TSLA) SolarCity Deal Makes No Sense, Tech Writers Tell CNBCFleetmatics (FLTX) Stock Skyrockets on Verizon DealEuropean Market Risks Remain so Stay Cautious on StocksJim Cramer -- Celgene Igniting a Rally in BiotechBuy These 5 Big Stocks for August GainsVirnetX (VHC) Stock Plummets After Ruling in Patent Claims Against AppleProcter & Gamble Must Prove This One Thing or ElseFB, F, GM: Jim Cramer's ViewsWhiting Petroleum (WLL) Stock Plummeting on Lower Oil PricesWhat to Look for When Fitbit (FIT) Reports Q2 Results15 Foods to Avoid if You Have High CholesterolCoca-Cola Stock Is Fizzling -- Buy These 2 Soda Stocks InsteadJim Cramer -- Expectations Are Low for Procter & Gamble so Buy MoreDow, S&P 500 Are Preparing for More Gains, These Charts ShowDollar General (DG) Stock Falls, Deutsche Bank DowngradesMorgan Stanley's 30 Best Stocks to Own for the Next 3 YearsGilead Sciences Has No Cure in Sight for Increasing CompetitionUber, Didi Chuxing Deal Is 'Win, Win,' GGV Capital's Tung Tells CNBC


Author Image

author:
author.

Related:
By on
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)